| Variables |
|
DFS |
|
| Univarite
HR(95% CI |
p |
Multivariate HR(95% CI) |
p |
| LDH
(<246 / ≥246) |
1.95(1.06-3.57) |
0.032 |
1.94(1.06-3.57) |
0.032 |
| Age
(<40 / ≥40) |
0.87(0.39-1.96) |
0.738 |
- |
- |
| Gender
(Male / female) |
1.74(0.95-3.19) |
0.074 |
1.74(0.95-3.19) |
0.075 |
| ALP
(<129 / ≥129) |
1.04(0.52-2.08) |
0.909 |
- |
-
|
| Creatinin
(<1.3 / ≥1.3) |
0.72(0.10-5.22) |
0.764 |
- |
-
|
| Fibrinogen group
(<400 /≥400) |
1.05(0.50-2.23) |
0.892 |
- |
-
|
| Donor status
(gender match / gender mismatch) |
1.03(0.53-2.02) |
0.931 |
- |
-
|
| Diagnosis
(Acute leukemia / Others) |
1.27(0.64-2.54) |
0.485 |
- |
-
|
| Time –to-tx interval (months
(<12months / >12months) |
1.67(0.91-3.09) |
0.100 |
- |
-
|
| HLA match
(full match / ≥1 mismatch) |
1.17(0.49-2.78) |
0.731 |
- |
- |
| Conditioning regimen
(Myeloablative / Nonmyeloablative) |
1.43(0.75-2.73) |
0.280 |
- |
- |
| CD34+ group
(<8 / >8 (106/kg)) |
0.63(0.26-1.54) |
0.311 |
- |
- |
